Daniel S. Lorrain is CSO at Contineum Therapeutics, Inc. (CTNM). They have made 4 open-market trades across 1 company since 2024, most recently 2026-07-09.
CIK 0001861550
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTNM | 135,202 | $956K |
Shares reported on the most recent Form 4, priced at the 2026-07-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTNM | SELL · 10b5-1 | 2026-07-08 | 2026-07-10 | $16.00 | $17K | -3.0% | -4.6% | -12.9% |
| CTNM | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $15.99 | $595K | -1.5% | +7.3% | -9.6% |
| CTNM | SELL · 10b5-1 | 2026-06-01 | 2026-06-01 | $13.16 | $55K | -8.6% | +17.6% | +25.2% |
| CTNM | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $13.12 | $55K | +6.2% | -1.4% | +18.9% |
| CTNM | SELL · 10b5-1 | 2026-04-06 | 2026-04-06 | $13.43 | $56K | -0.4% | +11.6% | +16.8% |
| CTNM | SELL · 10b5-1 | 2026-03-02 | 2026-03-02 | $15.01 | $63K | -9.6% | -12.3% | -14.8% |
| CTNM | SELL | 2026-02-24 | 2026-02-26 | $16.02 | $130K | -13.6% | -19.7% | -13.4% |
| CTNM | SELL | 2026-02-19 | 2026-02-20 | $16.00 | $2K | -5.5% | -21.0% | -8.5% |
| CTNM | SELL · 10b5-1 | 2026-02-11 | 2026-02-13 | $16.00 | $6K | +9.4% | -7.3% | -1.8% |
| CTNM | SELL | 2026-02-03 | 2026-02-05 | $14.94 | $62K | +5.1% | -6.5% | +2.9% |
| CTNM | SELL | 2026-01-05 | 2026-01-06 | $10.44 | $44K | +24.1% | +53.1% | +42.1% |
| CTNM | SELL · 10b5-1 | 2025-12-23 | 2025-12-30 | $12.23 | $102K | -20.0% | +27.4% | +8.7% |
| CTNM | SELL · 10b5-1 | 2024-11-25 | 2024-11-27 | $16.02 | $16K | -3.9% | -4.0% | -49.8% |
| CTNM | SELL · 10b5-1 | 2024-11-18 | 2024-11-20 | $16.38 | $201K | +4.1% | -2.0% | -46.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.